Utama › Artritis Psoriatik › Tennessee
Kajian klinikal Artritis Psoriatik di Tennessee
7 kajian untuk Artritis Psoriatik sedang mencari peserta di lokasi di Tennessee.
Bandar di Tennessee
Teks kajian rasmi (Bahasa Inggeris)
A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines
- West Tennessee Research Institute, Jackson
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 17 Sep 2026 · NCT06671483Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis and Anti-TNFα Inadequate Response
- Clinical Site, Jackson
- Clinical Site, Memphis
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 11 Sep 2026 · NCT06641089Continuation Study of Zasocitinib in Adults With Psoriatic Arthritis
- West Tennessee Research Institute, Jackson
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 9 Sep 2026 · NCT07286058Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry
- Monroe Carrell Jr. Children's Hospital at Vanderbilt, Nashville
Mengambil pesertaKajian pemerhatian
Sehingga umur 21 · Semua jantina · Dikemas kini 27 Ogo 2026 · NCT02418442A Study to Learn if Bimekizumab Given in Different Ways is Safe and Moves Similarly Throughout the Body Over Time in Adults
- Pa0019 116, Jackson
- Pa0019 138, Murfreesboro
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 6 Jul 2026 · NCT07290036Study of Targeted Therapies for the Treatment of Adult Participants With Active Psoriatic Arthritis
- Private Practice - Dr. Ramesh C. Gupta I /ID# 272897, Memphis
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 18 Dis 2025 · NCT06865105Guselkumab vs Golimumab in PsA TNF Inadequate Responder Patients
- Cumberland Rheumatology, Crossville
Mengambil pesertaFasa 3
Umur 18 hingga 80 · Semua jantina · Dikemas kini 9 Okt 2025 · NCT05669833Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.